AZURA OPHTHALMICS
Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatment options are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
AZURA OPHTHALMICS
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.azuraophthalmics.com
Total Employee:
11+
Status:
Active
Total Funding:
36 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress WP Rocket Plausible Analytics
Similar Organizations
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Brandon BioCatalyst
Brandon BioCatalyst investment in Grant - Azura Ophthalmics
Ganot Capital
Ganot Capital investment in Series C - Azura Ophthalmics
Brandon Capital
Brandon Capital investment in Series C - Azura Ophthalmics
TPG Biotech
TPG Biotech investment in Series C - Azura Ophthalmics
OrbiMed
OrbiMed investment in Series C - Azura Ophthalmics
Ganot Capital
Ganot Capital investment in Series B - Azura Ophthalmics
OrbiMed
OrbiMed investment in Series B - Azura Ophthalmics
Brandon Capital
Brandon Capital investment in Series B - Azura Ophthalmics
TPG Biotech
TPG Biotech investment in Series B - Azura Ophthalmics
Official Site Inspections
http://www.azuraophthalmics.com Semrush global rank: 12.8 M Semrush visits lastest month: 79
- Host name: 159.89.210.140
- IP address: 159.89.210.140
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62